SBIR/STTR Research Award

Micro-LFS Assays for Low-Pain Cardiac Marker Testing

Award identifier 953b4b788b480ad6e7fa4111e1f54e19169433bd909c7f67b5f6a70489affd34Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$100,000

Program and phase

SBIR · Phase I

Award year

2005

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
MICROPLUMBERS MICROFLUIDIC SCIENCES LLC
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
PHS2005-2
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Several organizations are currently developing relatively pain-free methods for extracting small quantities of whole blood (< 1 microliter) from patients. Those methods have the potential to transform routine IVD screening and home testing as patient acceptance of frequent testing is likely to be much improved. One of the areas this will be of great benefit is in cardiac tissue injury screening as well as in post-occurrence monitoring. However, there are currently no cardiac marker assays that function with such small sample volumes. MicroPlumbers Microsciences LLC proposes to develop an inexpensive cardiac marker screening and monitoring device that is compatible with recently developed low-pain microvolume blood extraction devices. The device will rely on microminiaturized lateral flow strip technology to provide a platform for sandwich and competitive immunoassays. The method will be demonstrated with commercially available assay chemistry for Troponin I. MicroPlumbers Microsciences has proprietary technology for the integration and miniaturization of lateral flow technology into microfluidic channels. Furthermore, MicroPlumbers has worked for over a year under contract with a company on a microminiaturized glucose sensor that is designed to utilize their demonstrated device for low pain microvolume blood extraction based on electronic lancing. In Phase I, MicroPlumbers Microsciences will attempt to demonstrate the feasibility of miniaturizing a lateral flow assay for Troponin I, specifically to show that a sample of less than one microliter can produce a visible indicator and control line. During Phase II, a beta disposable prototype will be developed that is capable of a semiquantitative cardiac marker assay on 100 nL to 1 microliter of whole blood. Further, low-pain blood extraction and lateral flow technology will be seamlessly integrated in order to minimize the sample volume required, and thus the level of pain associated with its extraction.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.